🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07603076
Recruiting Observational

Assessment of Venous Insufficiency and Clinical Features in Lipedema

NCT07603076 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-06-20
Last updated
2026-07-14

Condition(s) studied

LipedemaVenous InsufficiencyVenous DiseaseDisability Physical

Investigational drug(s) / intervention(s)

Venous Doppler UltrasonographyNumeric Rating ScaleLower Extremity Functional ScaleShort Form-12Lower Extremity Circumference at Standardized Anatomical Landmarks (cm)Clinical Staging

Venous Doppler Ultrasonography: Participants will undergo lower extremity venous Doppler ultrasonography to evaluate venous insufficiency findings, including venous reflux characteristics, affected venous segments, and venous diameters in the superficial and deep venous systems.

Numeric Rating Scale: Pain intensity will be evaluated using the Numeric Rating Scale, ranging from 0 (no pain) to 10 (worst imaginable pain).

Lower Extremity Functional Scale: Functional status will be assessed using the Lower Extremity Functional Scale. The total score ranges from 0 to 80, with higher scores indicating better lower extremity function and lower disability levels.

Short Form-12: Health-related quality of life will be assessed using the SF-12 questionnaire, including the Physical Component Summary (PCS-12) and Mental Component Summary (MCS-12) scores. Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life.

Lower Extremity Circumference at Standardized Anatomical Landmarks (cm): Circumference of both lower extremities will be measured using a non-stretch tape measure at the ankle, calf, knee, and thigh according to standardized anatomical landmarks. Measurements will be recorded in centimeters.

Clinical Staging: Lipedema stage will be determined according to clinical examination findings and established diagnostic criteria.

Study summary

Lipedema is a chronic adipose tissue disorder characterized by disproportionate fat accumulation, pain, tenderness, edema, and functional impairment. Venous symptoms such as heaviness, swelling, and discomfort are frequently reported in individuals with lipedema; however, the relationship between venous Doppler ultrasonography findings and lipedema-related clinical manifestations remains insufficiently investigated. This cross-sectional controlled study aims to evaluate venous insufficiency parameters in patients with lipedema using Doppler ultrasonography and to examine their associations with pain severity, lower extremity function, disease severity, and quality of life.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Female participants aged 18 years or older * Clinically diagnosed lipedema according to established diagnostic criteria * Ability to provide written informed consent * Ability to complete clinical assessments and questionnaires Exclusion Criteria: * History of lower extremity venous surgery or sclerotherapy * Known peripheral arterial disease * Secondary lymphedema or other causes of lower extremity edema * Active infection, cellulitis, or inflammatory disease affecting the lower extremities * Pregnancy or postpartum period * Neurological, rheumatological, or musculoskeletal disorders significantly affecting lower extremity function * Malignancy or severe systemic disease * Inability to undergo venous Doppler ultrasonography * Inability to understand or complete study assessments and questionnaires

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Physical Medicine and Rehabilitation, Health Sciences University Sultan Abdulhamid Han Training and Research Hospital Istanbul Uskudar Recruiting

More Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07603076 on ClinicalTrials.gov ↗ ← All trials in Turkey